Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.77B |
| 2 |
Microsoft
MSFT
|
$1.65B |
| 3 |
NVIDIA
NVDA
|
$1.47B |
| 4 |
Gilead Sciences
GILD
|
$1.13B |
| 5 |
Kroger
KR
|
$1.03B |
Top Sells
| 1 |
Procter & Gamble
PG
|
$1.34B |
| 2 |
Apple
AAPL
|
$1.23B |
| 3 |
United Parcel Service
UPS
|
$1.09B |
| 4 |
American Express
AXP
|
$999M |
| 5 |
JPMorgan Chase
JPM
|
$969M |
Sector Composition
| 1 | Technology | 24.89% |
| 2 | Financials | 15.95% |
| 3 | Healthcare | 15.37% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Pinnacle West Capital
PNW
$10.7B
| $393K | ﹤0.01% |
4,388
+1,116
| +34% | +$99.8K |
|
1727
Ardelyx
ARDX
$1.58B
| $383K | ﹤0.01% |
97,599
-4,376
| -4% | -$17.2K |
|
1728
Immunovant
IMVT
$2.81B
| $382K | ﹤0.01% |
23,889
-1,141
| -5% | -$18.3K |
|
1729
Textron
TXT
$14.5B
| $377K | ﹤0.01% |
4,690
-237,137
| -98% | -$19M |
|
1730
Fidelity National Financial
FNF
$16.4B
| $376K | ﹤0.01% |
6,700
-26,858
| -80% | -$1.51M |
|
1731
Natural Gas Services Group
NGS
$340M
| $370K | ﹤0.01% |
+14,347
| New | +$370K |
|
|
ARDT
1732
Ardent Health, Inc.
ARDT
$1.84B
| $363K | ﹤0.01% |
26,595
-468,371
| -95% | -$6.4M |
|
1733
Amphastar Pharmaceuticals
AMPH
$1.36B
| $359K | ﹤0.01% |
15,618
-1,295
| -8% | -$29.7K |
|
1734
Geron
GERN
$880M
| $352K | ﹤0.01% |
249,489
-2,734,810
| -92% | -$3.86M |
|
1735
Kodiak Sciences
KOD
$452M
| $345K | ﹤0.01% |
+92,505
| New | +$345K |
|
|
AVDL
1736
Avadel Pharmaceuticals
AVDL
$1.46B
| $339K | ﹤0.01% |
+38,306
| New | +$339K |
|
1737
BCE
BCE
$22.8B
| $337K | ﹤0.01% |
+15,223
| New | +$337K |
|
1738
Dyne Therapeutics
DYN
$1.88B
| $324K | ﹤0.01% |
34,018
-2,304
| -6% | -$21.9K |
|
1739
Mammoth Energy Services
TUSK
$113M
| $323K | ﹤0.01% |
115,212
+53,413
| +86% | +$150K |
|
1740
Syndax Pharmaceuticals
SNDX
$1.39B
| $319K | ﹤0.01% |
34,085
-1,877
| -5% | -$17.6K |
|
1741
FirstEnergy
FE
$25.1B
| $319K | ﹤0.01% |
+7,924
| New | +$319K |
|
1742
CenterPoint Energy
CNP
$24.5B
| $318K | ﹤0.01% |
8,643
-1,439
| -14% | -$52.9K |
|
1743
Red River Bancshares
RRBI
$438M
| $315K | ﹤0.01% |
5,358
| – | – |
|
1744
Nutanix
NTNX
$18.4B
| $308K | ﹤0.01% |
4,029
-698
| -15% | -$53.4K |
|
1745
HF Sinclair
DINO
$9.65B
| $308K | ﹤0.01% |
7,487
+1,394
| +23% | +$57.3K |
|
1746
Teva Pharmaceuticals
TEVA
$21.2B
| $294K | ﹤0.01% |
17,534
-120,602
| -87% | -$2.02M |
|
|
ARTV
1747
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$75.8M
| $293K | ﹤0.01% |
194,108
| – | – |
|
1748
Southwest Airlines
LUV
$16.3B
| $289K | ﹤0.01% |
+8,917
| New | +$289K |
|
1749
Ramaco Resources Class B
METCB
$1.08B
| $289K | ﹤0.01% |
35,292
-884
| -2% | -$7.23K |
|
1750
Sunrun
RUN
$3.79B
| $275K | ﹤0.01% |
+33,562
| New | +$275K |
|